HCA Healthcare, Inc. $HCA Shares Sold by Andra AP fonden

Andra AP fonden lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 5.6% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 31,900 shares of the company’s stock after selling 1,900 shares during the quarter. Andra AP fonden’s holdings in HCA Healthcare were worth $13,596,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently added to or reduced their stakes in the company. DNB Asset Management AS raised its stake in HCA Healthcare by 0.7% during the 3rd quarter. DNB Asset Management AS now owns 33,960 shares of the company’s stock worth $14,474,000 after acquiring an additional 246 shares in the last quarter. Hohimer Wealth Management LLC purchased a new position in shares of HCA Healthcare during the third quarter worth about $632,000. West Family Investments Inc. boosted its stake in HCA Healthcare by 31.5% during the 3rd quarter. West Family Investments Inc. now owns 806 shares of the company’s stock worth $344,000 after purchasing an additional 193 shares during the period. Advisor OS LLC increased its stake in HCA Healthcare by 9.0% in the third quarter. Advisor OS LLC now owns 1,356 shares of the company’s stock valued at $578,000 after purchasing an additional 112 shares during the period. Finally, Interchange Capital Partners LLC grew its holdings in shares of HCA Healthcare by 15.8% during the third quarter. Interchange Capital Partners LLC now owns 4,380 shares of the company’s stock worth $1,867,000 after buying an additional 596 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on HCA shares. Sanford C. Bernstein set a $541.00 target price on HCA Healthcare in a report on Monday, February 9th. TD Cowen reissued a “buy” rating on shares of HCA Healthcare in a research note on Wednesday, January 28th. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price target on the stock. in a research note on Monday, December 15th. Wells Fargo & Company lifted their price objective on HCA Healthcare from $452.00 to $481.00 and gave the company an “equal weight” rating in a report on Friday, January 30th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Sixteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $534.50.

HCA Healthcare Price Performance

HCA opened at $528.69 on Friday. The business has a 50-day moving average of $493.99 and a 200-day moving average of $459.94. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $552.90. The company has a market capitalization of $118.23 billion, a PE ratio of 18.63, a price-to-earnings-growth ratio of 1.62 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the business posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is 10.15%.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Analyst upgrade/price-target lift — Mizuho set a new $585 price target for HCA, reinforcing bullish analyst sentiment and helping support the stock’s rally. Read More.
• Positive Sentiment: Post‑earnings momentum — Analysts and writeups (Zacks) highlight HCA’s strong post‑earnings performance (EPS beat and raised FY26 guidance), which is a key reason for recent share gains. Read More.
• Positive Sentiment: Investor roadshow / conference calendar — HCA will present at multiple March healthcare conferences (TD Cowen, Raymond James, Barclays, Leerink, Oppenheimer), increasing institutional visibility and liquidity. Read More.
• Positive Sentiment: Expansion & facility investments — TriStar (an HCA division) is planning a $21M freestanding ER in Fairview and HCA (with Ascension) is targeting high‑growth markets with ER builds, signaling organic growth and franchise expansion. Read More.
• Positive Sentiment: Market strategy: ER build partnership — Coverage on HCA and Ascension targeting growth markets with ER builds points to disciplined capital deployment to capture patient volumes. Read More.
• Positive Sentiment: Quality recognition — A local report highlights high marks for HCA on CABG outcomes, which supports reputation and could help referrals/volume over time. Read More.
• Positive Sentiment: Brand and reputation wins — HCA and several systems made Fortune’s Most‑Admired list, a positive for reputation and hiring/partnerships. Read More.
• Neutral Sentiment: Local market developments — Coverage of Northeast Florida health‑care development (HCA, Baptist, Ascension St. Vincent’s) outlines competitive dynamics; useful for regional growth outlook but not an immediate system‑wide catalyst. Read More.
• Neutral Sentiment: New clinic opening — HCA Florida’s North Florida Hospital launched a test‑and‑treat clinic (local operational expansion), positive for access but a limited impact on consolidated results. Read More.
• Neutral Sentiment: Governance / compensation update — HCA disclosed its 2026 executive bonus plan and a longtime board member will retire; watch for details tying pay to metrics, but this is mostly governance housekeeping. Read More.
• Neutral Sentiment: Comparative performance pieces — A Yahoo Finance comparison of HCA vs. peer healthcare stocks offers context for investors but contains no new company-specific catalyst. Read More.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the transaction, the executive vice president owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 15,214 shares of company stock valued at $7,797,595 in the last quarter. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.